CA-MIDEA-GROUP
10.7.2024 10:51:29 CEST | Business Wire | Press release
Midea Group, recognized as a leading global technology and innovation enterprise, has successfully completed its 1H 2024 Campus Recruitment Tour with the final event on July 6th at Stanford University. These recruitment activities also represent a significant step in the company's ongoing pursuit of global expansion and the strategic localization of innovation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240709152530/en/
Midea Group's 2024 1H Overseas Campus Recruitment Tour at Stanford University (Photo: Business Wire)
With a diverse portfolio encompassing smart home solutions, industrial technology, building technology, robotics and automation, and innovative businesses, Midea Group has reaffirmed its dedication to global markets through this comprehensive recruitment initiative. Every year, approximately 15-20% of Midea Group's campus recruits have overseas study backgrounds, significantly enriching the company's international talent pool.
Highlights of the 2024 Midea Campus Recruitment:
- Over 3000 candidates participated in the event
- Over 4 countries and 20 engaging campus offline events conducted
- Over 10 specialized roundtables tailored for doctoral candidates
In-Depth Strategic Sessions:
- Leadership Insights: Keynote sessions led by Midea's CTO, CPO, and other executives provided visionary perspectives on the future of technology and Midea's pivotal role.
- Cultural Deep Dive: Emphasizing Midea's people-centric philosophy, the sessions highlighted the company's commitment to employee wellness, benefits, and personal growth.
- Innovation Showcase: Featuring Midea's expansive R&D network, including the Central Research Institute driving the "2+4+N" global R&D strategy, solidifying Midea's leadership in technological innovation.
Interactive and Immersive Experiences:
- Q&A Sessions: Transparent discussions on Midea's values, opportunities, and expectations.
- Roundtable Discussions: In-depth dialogues on R&D initiatives, career growth, and global presence.
- Alumni Sharing: Personal growth stories from alumni provided firsthand insights into career opportunities within Midea.
A Clear Path to Recruitment:
- Overseas Students Exclusive Channel: Overseas students graduating from January 2024 to December 2025 are all our target candidates and are allowed to submit resumes online.
- Process Clarity: Candidates were guided through a transparent application, interview, and job offer process.
- Diverse Opportunities: Roles spanning R&D, AI, IT, engineering, and more showcased Midea's commitment to diverse skill sets and professional interests.
- Global Outlook: With opportunities in over 40 global cities, Midea offered candidates a chance to work in multicultural environments.
Midea's Ongoing Commitment
From the UK to Germany, Japan, and the United States, Midea's 1H 2024 recruitment journey underscores its steadfast commitment to creating an innovative, inclusive, and open-minded platform. The company continues to invest significantly in its people and R&D, ensuring it remains at the forefront of technological advancement.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240709152530/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Spotlight Medical Announces Successful Independent Evaluation of Its Digital Slide-Based Test for Assessing Recurrence Risk in Early Breast Cancer22.10.2026 12:18:00 CEST | Press release
An independent, blinded evaluation of 620 patients from the phase III PANTHER trial identified nearly one-quarter as Low Risk despite clinically high-risk breast cancer, with favorable ten-year outcomes. Spotlight Medical, a company developing AI-powered prognostic tests in oncology, today announced results from an independent evaluation of myStage Dx, its CE-IVDR-marked test for assessing recurrence risk in patients with hormone receptor-positive, HER2-negative early breast cancer. The study was conducted by researchers at Karolinska Institutet in Sweden. Independent, Blinded Evaluation Using Phase III Trial Data The study used data from 620 patients enrolled in PANTHER, an international randomized phase III trial comparing dose-dense with standard chemotherapy. myStage Dxpredictions were generated blinded to clinical outcomes. Researchers at Karolinska Institutet linked the predictions to patient outcomes and independently assessed prognostic performance according to a prespecified p
Zoomtopia: Zoom lancerer nye AI-funktioner22.10.2026 12:13:00 CEST | Pressemeddelelse
Zoom vil forkorte vejen fra mødebeslutning til udført arbejde. På konferencen Zoomtopia præsenterer virksomheden Unified Context Layer – et fælles informationslag, der forbinder samtaler, dokumenter og data, så AI kan forstå sammenhængen og hjælpe med de næste skridt. Samtidig lanceres flere nye AI-produkter og -funktioner, der skal gøre det lettere at omsætte diskussioner og beslutninger til handling. Der er multimedier i denne pressemeddelelse. Se hele meddelelsen her: https://www.businesswire.com/news/home/20261021318859/da/ I møder og samtaler træffes vigtige beslutninger, og virksomheder får værdifuld indsigt i deres kunder. En kundedialog kan begynde i et møde, fortsætte i telefonen og derefter gå over i en chat. Når informationen spredes mellem forskellige værktøjer, bliver det svært for både medarbejdere og AI-agenter at få et samlet billede af, hvad der er blevet sagt og besluttet. Resultatet er, at værdifuld tid går med at finde ud af, hvad der er blevet sagt og besluttet, og
TACTICAAI and NVIDIA Collaborate to Scale Agentic AI Capabilities with NVIDIA Nemotron22.10.2026 12:01:00 CEST | Press release
Collaboration brings together TACTICAAI’s operational decision-intelligence technology and NVIDIA AI capabilities to advance reasoning, autonomous analysis and video intelligence for real-world deployment TACTICAAI, an operational decision-intelligence company, today announced a collaboration with NVIDIA to advance and scale the deployment of agentic AI capabilities. The companies will work together to integrate and optimize NVIDIA Nemotron models within TACTICAAI’s multi-intelligence platform, with a focus on expanding these capabilities and supporting deployment with major customers internationally. The collaboration was announced at NVIDIA GTC Berlin. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022054475/en/ TACTICA AI and NVIDIA Collaborate to Scale Agentic AI Capabilities with NVIDIA Nemotron (Graphic: AETOSWire) The collaboration with NVIDIA builds on the company’s existing technology, integrating selected NVIDIA
BeOne Medicines to Announce Third Quarter 2026 Financial Results on November 522.10.2026 12:01:00 CEST | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its third quarter 2026 financial results on Thursday, November 5, 2026, before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com.To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has
Bregal Milestone Backs Nethive With Majority Growth Investment and JoyComm Acquisition22.10.2026 10:00:00 CEST | Press release
Partnership to support Nethive’s next phase of growth as a leading cybersecurity services and software platform Bregal Milestone, a leading European software growth private equity firm, today announced a majority growth investment in Nethive S.p.A. (“Nethive” or the “Company”), a leading Italian cybersecurity services and software provider. Alongside its investment in Nethive, Bregal Milestone has also backed Nethive’s acquisition of IT security specialist Joy Comm S.r.l. (“JoyComm”). Founded in 2014 by Alessandro Bellato and Diego Rocco, Nethive has become a trusted cybersecurity partner to blue-chip enterprises, SMEs, and public-sector organizations across Italy. Its platform spans managed security services, professional services and technology resale, helping organizations protect critical infrastructure and networks, strengthen cyber resilience and reduce operational complexity. Nethive combines deep technical expertise with 24/7 monitoring, threat detection and response, risk and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom